Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome

Bone Marrow Transplantation

Volumn 44, Issue 9, 2009, Pages 595-599

  Hardak, E ^a   Yigla, M ^a   Avivi, I ^b   Fruchter, O ^a   Sprecher, H ^c   Oren, I ^d  

^a Division of Pulmonary Medicine   (Israel)

^b B Rappaport Faculty of Medicine ^*  (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

^d Infectious Diseases Unit   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASPERGILLUS; BRONCHOSCOPY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOCOMPROMISED PATIENT; INTERMETHOD COMPARISON; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ASPERGILLUS; BONE MARROW TRANSPLANTATION; BRONCHOALVEOLAR LAVAGE FLUID; DNA, FUNGAL; EARLY DIAGNOSIS; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; POLYMERASE CHAIN REACTION; PULMONARY ASPERGILLOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70749134843     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.65     Document Type: Article

References (16)

1. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608-615.
2. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases. Rev Infect Dis 1990; 12: 1147-1201.
3. Von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: Early diagnosis improves survival. Respiration 1995; 62: 341-347.
4. Reichenberger F, Habicht J, Matt P, Frei R, Solèr M, Bolliger CT et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999; 24: 1195-1199.
5. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992; 86: 243-248.
6. Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: Clinical results. Clin Infect Dis 2001; 33: 428-435.
7. Hayette MP, Vaira D, Susin F, Boland P, Christiaens G, Melin P et al. Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid. J Clin Microbiol 2001; 39: 2338-2340.
8. Musher B, Fredricks D, Leisenring W, Arunmozhi Balajee S, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004; 42: 5517-5522.
9. Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-Mösch C et al. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two step PCR. J Clin Microbiol 1999; 37: 3865-3871.
10. Einsele H, Quabeck K, Muller KD, Hebart H, Rothenhöfer I, Löffler J et al. Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation. Lancet 1998; 352: 1443.
11. Maertens J, Theunissen K, Lodewyck T, Lagrou K, Van Eldere J. Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders. Mycoses 2007; 50: 2-17.
12. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. on behalf of the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
13. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive Aspergillosis following hematopoietic cell transplantation: Outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531-540.
14. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW et al., on behalf of the Invasive Fungal Infections Group of the European Study Organisation for Research and Treatment of Cancer and the Global Aspergillus Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415.
15. Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-1402.
16. de Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.